期刊文献+

小儿急性B淋巴细胞白血病微小残留病免疫表型的改变及临床预后分析 被引量:4

Analysis of immunophenotypic modulation in childhood B-ALL with positive minimal residual disease and the clinical analysis of prognosis
原文传递
导出
摘要 目的探讨使用流式细胞术检测出的微小残留病(MRD)在急性淋巴细胞白血病(ALL)化疗阶段发生表面抗原的改变以及MRD水平、出现时期与预后关系。方法2001年10月至2006年3月北京大学人民医院儿科收治63例出现过MRD阳性的急性B淋巴细胞白血病(B-ALL)患儿,同时使用流式细胞术及PCR检测MRD。结果(1)在63例流式细胞术检测MRD阳性患儿中,有23例骨髓复发,1例脑膜白血病,6例失访,1例因严重感染死亡,33例随访至今无病生存。(2)共有147次流式细胞术检测结果呈阳性。有78次(53.06%)MRD检测结果至少有1个抗体荧光强度的变化,其中出现一个抗体强度变化的为33次(22.44%),2个抗体荧光强度变化为22次(14.96%),3个及3个以上荧光强度变化为23次(15.64%)。CD10、CD45、CD34抗体荧光强度变化频率最高。(3)共有10例患儿在复发时行免疫分型检查,8例(8/10,80%)与初治时有抗体荧光强度变化。(4)MRD为10-3水平组存活率明显低于10-4水平组(P=0.0007)。(5)维持化疗和(或)停药期间出现MRD阳性组存活率明显低于巩固化疗期间出现MRD阳性组(P=0.024)。结论在小儿B-ALL治疗过程中,MRD的免疫表型可能会发生变化,在检测过程中应加以注意。如果出现10-3水平MRD或者是在维持化疗和(或)停药期间出现MRD,应及时干预。 Objective To investigate the immunophenotypic modulation of MRD detected by flow cytometry in the course of treatment with the relationship of prognosis with the level of MRDe and the time of the appearance of MRD.Methods From 2001 to 2006,63 patients with B-ALL which occurred with MRD were enrolled.These patients were detected MRD by flow cytometry and PCR.Results 1)These were 23 patients with bone marrow relapse,1 patient with the leukemia in the central nerve system,1 patient died with severe infection,32 patients followed up were disease-free.2)A total of 147 positive results were detected by flow cytometry;78 results had the modulation of immunophenotype;33 results had one membrane antigen changed;22 results had two membrane antigens changed;23 results had three or more membrane antigens changed.The changes of fluorescent intensity of CD10,CD45,CD34 were most frequent.3)Eight of 10 patients had the immunophenotypic modulation at the time of relapse.4)Patients with MRD at the levels of 10^-3 had significantly lower disease-free survival compared with patients with MRD at the levels of 10^-3.5)Patients with positive results in the course of maintenance treatment or end of therapy had significantly lower disease-free survival compared with patients with positive results in the treatment of consolidation.Conclusion The immunophenotype of MRD of childhood B-ALL may change during the chemotherapy.We should take this into consideration during the detection.If the MRD appears in the course of maintenance treatment or end of therapy,we may take measures immediately.
出处 《中国实用儿科杂志》 CSCD 北大核心 2008年第4期276-280,共5页 Chinese Journal of Practical Pediatrics
关键词 免疫表型 微小残留病 急性B淋巴细胞白血病 Immunophenotype Minimal residual disease B-ALL
  • 相关文献

参考文献15

  • 1Oelschlagel U, Nowak R, Schaub A, et al. Shift of aberrant antigen expression at relapse or at treatment failure in acute leukemia [J]. Cytometry,2000,42:247-253.
  • 2van Wering ER, Beishuizen A, Roeffen ET, et al. lmmunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia[ J ]. Leukemia, 1995,9 : 1523-1533.
  • 3Smith EC, Sancho J, Hancock ML, et al. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia[J]. Blood,2000,96:2691-2696.
  • 4Dworzak MN, Froschl G, Printz D, et al. Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia[J]. Blood ,2002, 99:1952-1958.
  • 5Coustan-Smith E, Sancho J, Behm FG, et al. Prognostic importance of measuring early cleance of leukemia cells by flow cytometry in childhood acute lymphoblastic leukemia[J]. Blood ,2002, 100:52-58.
  • 6顾龙君,孙桂香,卢新天,汤静燕,吴敏媛.小儿急性淋巴细胞白血病诊疗建议(第二次修订草案)[J].中华儿科杂志,1999,37(5):305-307. 被引量:306
  • 7程翼飞,张乐萍,刘桂兰,田开功.TCRδ胚系通用Taqman探针在检测儿童急性B淋巴细胞白血病微量残留病中的应用[J].中华血液学杂志,2005,26(9):559-561. 被引量:2
  • 8刘乐宇,孙金英,殷慧君.急性淋巴细胞白血病化疗缓解后TCRγ基因检测的意义[J].中华血液学杂志,1998,19(7):353-355. 被引量:7
  • 9Gaipa G, Basso G, Maglia O, et al. Drug-induced immunophenotypic modulation in childhood ALL: implication for minimal residual disease detection [ J ]. Leukemia,2005,19 : 49-56.
  • 10van Wering ER, van Der Lindan-schewer EV, Szczepanski T, et al. Regenerationg normal B-cell precursors during and after treatment of acute lymphoblastic leukemia: implication for monitoring residual disease [ J ]. Br J Heamatol, 2000, 110: 139- 146.

二级参考文献7

  • 1殷慧君,小儿急性白循化学治疗,1995年,55页
  • 2Pongers-Willemse M J, Verhagen OJ, Tibbe GJ, et al. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia, 1998,12:2006-2014.
  • 3Verhangen OJ, Willemse M J, Breunis WB, et al. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia. Leukemia,2000, 14:1426-1435.
  • 4Lucio P, Parreira A, van den Beem DMW, et al. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL. Leukemia,1999,13:419-427.
  • 5Dworzak MN, Fritsch G, Fleischer C ,et al. Comparative phenotype mapping of normal vs. malignant pediatric B-lymphopoiesis unveils leukemia-associated aberrations. Exp Hematol, 1998,26:305-313.
  • 6Szczepanski T, Beishuizen A, Ponger-Willemse MJ, et al. Cross-lineage T cell receptor gene rearrangement occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative targets for detection of minimal residual disease. Leukemia,1999,13:196-205.
  • 7Steward CG, Goulden NJ, Katz F, et al. A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor δ gene rearrangements between presentation and childhood B-lineage acute lymphoblastic leukemia. Blood, 1994, 83:1355-1362.

共引文献312

同被引文献31

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部